Intravenous Immunoglobulin Therapy: Confounding Effects on Serological Screening for Toxoplasmosis during Pregnancy
AUTOR(ES)
Pelloux, Hervé
FONTE
American Society for Microbiology
RESUMO
The serological diagnosis of toxoplasmic infection during pregnancy is intended to prevent congenital infection of the fetus. However, in the context of recurrent pregnancy loss intravenous immunoglobulin therapy can create a biological trap for the interpretation of serological results, with potentially serious consequences for the outcome of the pregnancy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=85593Documentos Relacionados
- Screening for toxoplasmosis during pregnancy.
- Screening for toxoplasmosis in pregnancy.
- Confounding variables in studying the effects of maternal alcohol consumption before and during pregnancy.
- Intravenous iron therapy: how far have we come?
- Evidence for Biliary Excretion of Vancomycin into Stool during Intravenous Therapy: Potential Implications for Rectal Colonization with Vancomycin-Resistant Enterococci
